Southwest Prostate Cancer Symposium

Westin Kierland Resort, Scottsdale, Arizona
December 9-11, 2021

innovations in urologic practice logo

A Must-Attend Event!

The Southwest Prostate Cancer Symposium (SPCS 2021) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices.

The goal of this educational program is to equip urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in prostate cancer care with the up-to-date clinical knowledge and tools they need to best treat their patients. The program aims to provide a technical update on all aspects of diagnosis and treatment of localized and advanced disease.

Program Co-Chair

Nelson N. Stone, MD

Nelson N. Stone, MD

Professor of Urology and Radiation Oncology
Icahn School of Medicine at Mount Sinai
3DBiopsy, Inc. Founder
New York, New York

Program Co-Chair

Richard G. Stock, MD

Richard G. Stock, MD

Professor of Radiation Oncology
Director of Genito-Urinary Radiation Oncology
Icahn School of Medicine at Mount Sinai
New York, New York

Keynotes from Prostate Cancer Experts

Attend Sessions

Connect with Peers and Experts

Agenda

The 2021 Southwest Prostate Cancer Symposium offers a robust program with multi-track sessions, including CME lectures, in Scottsdale from December 9-11, 2021.

Thursday, December 9, 2021

6:30am–7:00pm

Registration and Check-In

7:00am–7:50am

Breakfast Program

8:00am–5:00pm

Exhibits Open

8:00am–8:05am

Welcome and Introduction
Program Chairs: Nelson N. Stone, MD, and Richard G. Stock, MD

8:05am–12:00pm

Session 1: Prostate Biopsy 
Moderator: Samir S. Taneja, MD

8:05am–8:25am

Transperineal Prostate Biopsy: Office Procedure With and Without Fusion Targeting
Michael A. Gorin, MD

8:25am–8:50am

Transperineal Mapping Biopsy: Does Technique Matter?
Nelson N. Stone, MD

8:50am–9:15am

Prostate Cancer Detection Using 3D Shear Wave Elasticity Imaging
Thomas J. Polascik, MD

9:15am–9:50am

Management of Men With PI-RADS 4-5 Lesions and Negative Biopsy
Samir S. Taneja, MD

9:50am–10:10am

Break

10:10am–10:35am

Active Surveillance or Focal Therapy as Primary Management
Laurence Klotz, MD, FRCSC

10:35am–10:50am

Pathologist Perspective on Biopsy Results: Transperineal Mapping vs. Fusion Biopsy
M. Scott Lucia, MD

10:50am–11:15am

Utilization of Focal Therapy for Patients Discontinuing Active Surveillance of Prostate Cancer: Recommendations of an International Delphi Consensus
Thomas J. Polascik, MD

11:15am–12:00pm

Panel Discussion

12:00pm–12:20pm

Break

12:20pm–1:20pm

Lunch Program

1:30pm–5:00pm

Session 2: Hands-on Skills Laboratory for Prostate Biopsy and Focal Therapy Using Advanced Simulation Models
Moderator: Nelson N. Stone, MD
Stations are 30 min. There will be a 15-minute break at 3:00pm.

Transperineal Mapping Biopsy
Nelson N. Stone, MD, and Vassilios M. Skouteris, MD

Transperineal Office Biopsy With Local Anesthesia With PrecisionPoint and Koelis Trinity
Michael A. Gorin, MD

Transrectal Fusion Biopsy with Philips UroNav
Samir S. Taneja, MD

Micro-Ultrasound
Laurence Klotz, MD, FRCSC

Focal Cryotherapy
Thomas J. Polascik, MD

Focal One HIFU
TBD

Friday, December 10, 2021

6:30am–7:00pm

Registration and Check-In

7:00am–7:50am

Breakfast Program

8:00am–5:00pm

Exhibits Open

8:00am–12:00pm

Session 3: Radiation Therapy: Changing Environment
Moderator: Richard G. Stock, MD

8:00am–8:25am

Rectal Displacement Reduces Potential for Injury: Application of Different Technologies for EBRT and Brachytherapy
Richard G. Stock, MD

8:25am–8:50am

How to Select an Isotope for Brachytherapy: I-125, Pd-103, or Cs-111
Peter F. Orio III, DO, MS

8:50am–9:15am

Physics of Intraoperative Dose Boosting
Ren-Dih Sheu, PhD

9:15am–9:50am

Transperineal Mapping Biopsy Improves the Selection of Implant Alone or Combination Therapy in Intermediate-Risk Patients
Vassilios M. Skouteris, MD

9:50am–10:15am

Combining Therapy with SBRT and Brachytherapy
Richard G. Stock, MD

10:15am–10:30am

Break

10:30am–10:50am

How to Define Biochemical Cure After Brachytherapy
Juanita M. Crook, MD, FRCPC

10:50am–11:10am

Impact of Percent Positive Biopsy Cores on Cancer-Specific Mortality for Patients With High-Risk Prostate Cancer
Peter F. Orio III, DO, MS

11:10am–11:30am

Optimal Use of Androgen Deprivation With Brachytherapy in Men With Intermediate and High-Risk Prostate Cancer
Juanita M. Crook, MD, FRCPC

11:30am–12:00pm

Panel Discussion

12:00pm–12:20pm

Break

12:20pm–1:20pm

Lunch Program

1:30pm–5:00pm

Session 4: Hands-on Skills Laboratory for Radiation Protection Devices and Brachytherapy Using Advanced Simulation Models
Moderator: Richard G. Stock, MD
Stations are 30 min. There will be a 15-minute break at 3:00pm.

Placement of SpaceOar into Prostate Phantom
Richard G. Stock, MD

Placement of Barrigel into Prostate Phantom
Peter F. Orio III, DO, MS

Intraprostatic Brachytherapy Boost of the Region of Interest (ROI)
Juanita M. Crook, MD, FRCPC

Physics Planning for Partial Implants
Ren-Dih Sheu, PhD

Focal Brachytherapy
Nelson N. Stone, MD, and Vassilios M. Skouteris, MD

6:00pm–8:00pm

25th Anniversary Celebration

Saturday, December 11, 2021

6:30am–7:00pm

Registration and Check-In

7:00am–7:50am

Breakfast Program

8:00am–12:00pm

Exhibits Open

8:00am–10:00am

Session 5: Focal Therapy
Moderator: Thomas J. Polascik, MD

8:00am–8:20am

How to Utilize MRI for Focal Therapy Planning
Samir S. Taneja, MD

8:20am–8:40am

Focal Cryotherapy
Thomas J. Polascik, MD

8:40am–9:00am

Focal HIFU
Laurence Klotz, MD, FRCSC

9:00am–9:20am

Focal Brachytherapy
Peter F. Orio III, DO, MS

9:20am–9:40am

How to Interpret Post-Focal Therapy Biopsies
M. Scott Lucia, MD

9:40am–10:10am

Panel Discussion

10:10am–10:25am

Break

10:25am–12:30pm

Session 6: Advanced Prostate Cancer
Moderator: William K. Oh, MD

10:30am–10:50am

Advances in PET Scanning for Advanced Prostate Cancer
Richard G. Stock, MD

10:50am–11:10am

Treatment of Oligometastatic Disease
Juanita M. Crook, MD, FRCPC

11:10am–11:30am

Sequencing in Men With mCRPC and Influence of Germline Mutations
William K. Oh, MD

11:30am–12:00pm

Immunotherapy in Metastatic Prostate Cancer
Raoul S. Concepcion, MD, FACS

12:00pm–12:20pm

Identifying Mutations and Optimizing Use of PARP Inhibitors
William K. Oh, MD

12:20pm–1:20pm

Panel Discussion

1:20pm

Program Ends

Accommodations & Transportation

Westin Kierland Resort
6902 East Greenway Parkway
Scottsdale, AZ 85254

Discover a vitalizing oasis at The Westin Kierland Resort & Spa in Scottsdale, Arizona. Located near versatile dining and shopping at Kierland Commons, our hotel offers a stimulating experience in the Sonoran Desert. Thrill your kids at OdySea Aquarium, featuring SeaTrek Helmet Diving and a shark tour. Challenge yourself at The Westin Kierland Golf Club, our award-winning course designed by Scottsdale architect Scott Miller. Agave, The Arizona Spa & Salon, offers rejuvenating facials, manicures, pedicures, makeup services, and scalp treatments. End your day with a personalized in-room massage or simply recharge on your soft Heavenly® Bed. Experience something new and refreshing at our resort.

ROOM RESERVATIONS:
Hotel registration link: https://book.passkey.com/event/50251593/owner/8712/home

ROOM RATES:
Casita Suite – $349.00
Resort View King – $349.00

GROUND TRANSPORTATION:
We suggest Uber and Lyft. 

Here are some shuttle options we found but do not have experience with:

CONFERENCE ATTIRE:
Attire is business casual. Since meeting room temperatures and personal comfort levels vary, it is recommended that you bring a sweater or jacket to the educational activities.

For information about activities in Scottsdale, see this page from the Westin Kierland Resort: https://www.marriott.com/hotels/local-things-to-do/phxws-the-westin-kierland-resort-and-spa/

Invited Faculty

Co-Chair

Nelson N. Stone, MD

Nelson N. Stone, MD

Professor of Urology and Radiation Oncology
Icahn School of Medicine at Mount Sinai
3DBiopsy, Inc. Founder
New York, New York

Co-Chair

Richard G. Stock, MD

Richard G. Stock, MD

Professor of Radiation Oncology
Director of Genito-Urinary Radiation Oncology
Icahn School of Medicine at Mount Sinai
New York, New York

Juanita M. Crook, MD, FRCPC

Juanita M. Crook, MD, FRCPC

Professor of Radiation Oncology
Cancer Centre for the Southern Interior
University of British Columbia
Kelowna, British Columbia

Michael A. Gorin, MD

Michael A. Gorin, MD

Urologist
Urology Associates
Cumberland, Maryland

Laurence Klotz, MD, FRCSC

Laurence Klotz, MD, FRCSC

Chief, Division of Urology, Sunnybrook
Professor, Department of Surgery, University of Toronto
Sunnybrook Health Sciences Centre
Toronto, Ontario

William K. Oh, MD

William K. Oh, MD

Chief Medical Science Officer, Sema4,
and Clinical Professor of Medicine
Division of Hematology and Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

Peter F. Orio III, DO, MS

Peter F. Orio III, DO, MS

Vice Chair of Network Operations, Department of Radiation Oncology
Medical Director, Radiation Oncology
Dana-Farber/Brigham and Women’s Cancer Center
Assistant Professor of Radiation Oncology, Part-Time
Harvard Medical School
Boston, Massachusetts

Thomas J. Polascik, MD

Thomas J. Polascik, MD

Director, Urologic Oncology Fellowship
Professor of Surgery
Durham, North Carolina

Ren-Dih Sheu, PhD

Ren-Dih Sheu, PhD

Associate Professor
Department of Radiation Oncology
Icahn School of Medicine at Mount Sinai
New York, New York

Vassilios M. Skouteris, MD

Vassilios M. Skouteris, MD

Director, Brachytherapy Program
Hygeia Hospital
Athens, Greece

Samir S. Taneja, MD

Samir S. Taneja, MD

James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology
Vice Chair, Department of Urology
Co-Director, Smilow Comprehensive Prostate Cancer Center
NYU Grossman School of Medicine
New York, New York

CME Information

This conference has been accredited for 12.5 AMA PRA Category 1 CreditsTM.

Registration

During these times, Grand Rounds in Urology and the Southwest Prostate Cancer Symposium are committed to you. This meeting is being planned in accordance with federal and local guidance to be as safe as possible.

By registering for this conference, you agree to our standard Conference Registration and Attendance Terms and Conditions agreement, which is available online at: Conference Registration and Attendance Terms and Conditions.

COVID-19 DISCLAIMER: An inherent risk of exposure to COVID-19 and other more common contagions exists in any public place where people are present. COVID-19 is an extremely contagious disease that can lead to severe illness and even death in a small percentage of the population, especially those with weakened immune systems. For your safety and convenience, we are endeavoring to take appropriate precautions, as detailed above. Even with our best efforts, however, there is no guarantee that you can avoid exposure to COVID-19 or other common pathogens, whether at our conference or elsewhere. Please note that, as further detailed in our Conference Registration and Attendance Terms and Conditions Agreement (the “Registration Agreement”), which must be reviewed and agreed to during the registration process, all conference attendees voluntarily assume ALL RISKS related to any possible exposure to COVID-19. We encourage you to read the Registration Agreement carefully, as it contains other important terms, including other disclaimers and limitations on liability.

Support Opportunities

To inquire about support opportunities, please contact:

Marc Weathersby, Chief Marketing Officer
Tel: 434-817-2000, x193    Cell: 434-989-5508
Fax: 434-817-2020    mweathersby@cjp.com

Exhibit and Sponsor Prospectus

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

View content from previous Southwest Prostate Cancer Symposium meetings